FIGURE 3.
Kaplan–Meier survival curves of OS in rHCC patients with or without MVI in 13 months recurrence interval (A) and beyond 13 months recurrence interval (B). Kaplan–Meier survival curves of OS in MVI positive rHCC patients underwent adjuvant TACE or not in 13 months recurrence interval (C) and beyond 13 months recurrence interval (D). Abbreviations: OS, overall survival; rHCC, recurrent hepatocellular carcinoma; MVI, microvascular invasion; TACE, transcatheter arterial chemoembolization.